Michael Kappelman, MD

University of North Carolina at Chapel Hill

Poster(s):

• C0368 - Comparative Effectiveness of Vedolizumab versus Ustekinumab in Anti-TNF Experienced Patients With Crohn’s Disease
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET

• D0342 - Real World Evidence Comparing Vedolizumab and Ustekinumab in Anti-TNF Experienced Patients With Crohn’s Disease
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET